Alamar Biosciences (ALMR)Director bought ~$4M
Nicholas Naclerio, Director at Alamar Biosciences, bought ~$4M of Alamar Biosciences shares.
- ~$4M
- Approx. value · 235K sh @ $17.00
- 507K
- Holds after · shares reported
- Traded
- Apr 20, 2026
- Filed
- Apr 21, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 20, 2026 · this disclosureInsiderDirector purchased ~$4M of ALMR shares in the open market
What came next
- Apr 20, 2026Company filing · Form 8-K · Bylaws or charter, Other newsChanged its bylaws, charter or fiscal year, and reported other company news
- Apr 20, 2026Insider10% owner purchased ~$4M of ALMR shares in the open market
- May 8, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 10, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Alamar Biosciences
For Alamar Biosciences, OQRO holds 2 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALMR page.
How this filing works
Other disclosures at Alamar Biosciences
- USAspending.gov award recordSep 21, 2026
- USAspending.gov award recordSep 18, 2026
- USAspending.gov award recordSep 17, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 4Apr 21, 2026
Everything OQRO holds on this company is on its ALMR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data